Xtant Medical Holdings, Inc. (XTNT)
NYSEAMERICAN: XTNT · IEX Real-Time Price · USD
0.720
-0.025 (-3.38%)
May 31, 2024, 4:00 PM EDT - Market closed
Xtant Medical Holdings Market Cap
Xtant Medical Holdings has a market cap or net worth of $93.76 million as of May 31, 2024. Its market cap has increased by 28.43% in one year.
Market Cap
93.76M
Enterprise Value
117.89M
1-Year Change
28.43%
Ranking
Category
Stock Price
$0.72
Market Cap Chart
Since July 1, 2010, Xtant Medical Holdings's market cap has increased from $7.90M to $93.76M, an increase of 1,086.79%. That is a compound annual growth rate of 19.44%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 31, 2024 | 93.80M | -3.30% |
May 30, 2024 | 97.00M | 3.41% |
May 29, 2024 | 93.80M | -3.99% |
May 28, 2024 | 97.70M | -0.10% |
May 24, 2024 | 97.80M | -2.20% |
May 23, 2024 | 100.00M | -1.57% |
May 22, 2024 | 101.60M | 3.57% |
May 21, 2024 | 98.10M | 3.92% |
May 20, 2024 | 94.40M | 0.64% |
May 17, 2024 | 93.80M | 4.11% |
May 16, 2024 | 90.10M | -12.52% |
May 15, 2024 | 103.00M | -3.20% |
May 14, 2024 | 106.40M | 2.11% |
May 13, 2024 | 104.20M | -1.23% |
May 10, 2024 | 105.50M | - |
May 9, 2024 | 105.50M | -1.22% |
May 8, 2024 | 106.80M | 0.47% |
May 7, 2024 | 106.30M | -7.24% |
May 6, 2024 | 114.60M | 3.52% |
May 3, 2024 | 110.70M | -1.60% |
May 2, 2024 | 112.50M | 0.36% |
May 1, 2024 | 112.10M | -3.78% |
Apr 30, 2024 | 116.50M | -3.80% |
Apr 29, 2024 | 121.10M | -2.10% |
Apr 26, 2024 | 123.70M | 5.46% |
View and export this data all the way back to 2010.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Aurora Cannabis | 96.41M |
MSP Recovery | 95.52M |
KORU Medical Systems | 95.19M |
ProPhase Labs | 95.01M |
Eton Pharmaceuticals | 94.84M |
Elutia | 92.79M |
PMV Pharmaceuticals | 92.08M |
Relmada Therapeutics | 92.03M |